
"The doctor suggested I consider embryo chromosome screening. What is this? Do I need to do it?" As third-generation IVF becomes more common, such questions are becoming increasingly frequent. This article explains in simple terms what PGT-A is, who might benefit from it, and its limitations.
PGT-A involves extracting a small sample of trophoblast cells before embryo transfer to determine whether their chromosome count is normal (i.e., whether there are an extra or missing chromosome). Embryos with normal chromosomes have a higher chance of successful implantation and live birth, while the risk of miscarriage is lower.
For young women who have never undergone this procedure or those with only one unsuccessful attempt, a standard IVF program may suffice. Adding PGT-A may not improve the chances of a live birth; instead, it may increase costs and the risk of embryo loss. Whether to undergo PGT-A should be decided based on individual circumstances, not because "everyone else does it."
Decide whether to undergo PGT-A with your doctor. Consider your age, medical history, number of unsuccessful attempts, and the condition of the embryos. Reproductive doctors can help you make an informed decision. Our explanations aim to help you understand the concept, not to make decisions for you.